Literature DB >> 26810522

Freezing of gait in early Parkinson's disease: Nigral iron content estimated from magnetic resonance imaging.

Marguerite Wieler1, Myrlene Gee2, Richard Camicioli1, W R Wayne Martin3.   

Abstract

PURPOSE: Freezing of gait is a major source of disability associated with the progression of Parkinson's disease (PD). Our objective was to determine whether evolving changes in nigral iron content in association with declining motor function in early PD differentiates subjects who develop freezing from those who do not.
METHODS: A cohort of previously untreated individuals with early PD (n=19) was followed for 36 months clinically and with MRI. The cohort was divided into two groups based on the development of freezing during follow-up. A multiple gradient echo MRI sequence provided an index of basal ganglia iron content.
RESULTS: There were significant baseline differences between those who developed freezing (n=7) and those who did not (n=12) in Unified Parkinson's Disease Rating Scale motor scores, time to complete a 14 m walk and timed up and go. There was a significant correlation between the measured change in transverse relaxation in the lateral substantia nigra pars compacta and the change in motor score from baseline to 36 months (p=0.002). The freezing group showed a greater change in motor score and iron content than did the non-freezing group.
CONCLUSIONS: Individuals destined to develop freezing early in PD have more motor impairment at baseline, more rapid deterioration in motor function, and pars compacta changes suggestive of increased iron content in comparison to those who do not.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Freezing; Gait; Iron; MRI; Midbrain; Parkinson's disease

Mesh:

Substances:

Year:  2015        PMID: 26810522     DOI: 10.1016/j.jns.2015.12.008

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

Review 1.  Longitudinal Progression Markers of Parkinson's Disease: Current View on Structural Imaging.

Authors:  Jing Yang; Roxana G Burciu; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

Review 2.  Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Authors:  Usman Saeed; Jordana Compagnone; Richard I Aviv; Antonio P Strafella; Sandra E Black; Anthony E Lang; Mario Masellis
Journal:  Transl Neurodegener       Date:  2017-03-28       Impact factor: 8.014

Review 3.  Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.

Authors:  Usman Saeed; Anthony E Lang; Mario Masellis
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

4.  Low plasma serotonin linked to higher nigral iron in Parkinson's disease.

Authors:  Leslie C Jellen; Mechelle M Lewis; Guangwei Du; Xi Wang; Martha L Escobar Galvis; Stanislaw Krzyzanowski; Colt D Capan; Amanda M Snyder; James R Connor; Lan Kong; Richard B Mailman; Patrik Brundin; Lena Brundin; Xuemei Huang
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

Review 5.  [MRI Findings in Parkinson's Disease: Radiologic Assessment of Nigrostriatal Degeneration].

Authors:  Yun Jung Bae; Jong-Min Kim; Byung Se Choi; Yoo Sung Song; Yoonho Nam; Se Jin Cho; Jae Hyoung Kim; Sang Eun Kim
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-05-25

6.  Substantia Nigra Radiomics Feature Extraction of Parkinson's Disease Based on Magnitude Images of Susceptibility-Weighted Imaging.

Authors:  Qingguo Ren; Yihua Wang; Shanshan Leng; Xiaomin Nan; Bin Zhang; Xinyan Shuai; Jianyuan Zhang; Xiaona Xia; Ye Li; Yaqiong Ge; Xiangshui Meng; Cuiping Zhao
Journal:  Front Neurosci       Date:  2021-05-31       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.